NEW YORK (GenomeWeb) - NanoString Technologies reported after the close of the market Wednesday that its second quarter revenues increased 73 percent, attributable to collaboration revenue, instrument sales, and consumables pull-through.

For the three months ended June 30, the Seattle-based molecular diagnostics firm reported total revenues of $22.6 million compared to $13.1 million in the prior-year period, beating the average Wall Street analyst estimate of $19.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.